ULTRAGENYX PHARMACEUTICAL INC. - COMMON STOCK
43.65
08-January-25 15:45:00
15 minutes delayed
Stocks
-0.79
-1.78%
Today's range
43.28 - 44.78
ISIN
N/A
Source
NASDAQ
-
Ultragenyx to Participate in Orphan Neuro Panel at Cowen Healthcare Conference
28 Feb 2023 15:01:00 By Nasdaq GlobeNewswire
-
Ultragenyx Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Update
16 Feb 2023 15:01:00 By Nasdaq GlobeNewswire
-
09 Feb 2023 15:01:00 By Nasdaq GlobeNewswire
-
06 Jan 2023 15:01:00 By Nasdaq GlobeNewswire
-
Ultragenyx to Present at the 41st Annual J.P. Morgan Healthcare Conference
04 Jan 2023 05:00:00 By Nasdaq GlobeNewswire
-
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
21 Dec 2022 15:01:00 By Nasdaq GlobeNewswire
-
Ultragenyx to Present at Piper Sandler Healthcare Conference
22 Nov 2022 15:01:00 By Nasdaq GlobeNewswire
-
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
18 Nov 2022 15:05:00 By Nasdaq GlobeNewswire
-
Ultragenyx Announces Departure of Chief Financial Officer
10 Nov 2022 15:15:00 By Nasdaq GlobeNewswire
-
Ultragenyx to Present at Upcoming Healthcare Conferences
09 Nov 2022 15:01:00 By Nasdaq GlobeNewswire
-
Ultragenyx Reports Third Quarter 2022 Financial Results and Corporate Update
02 Nov 2022 15:05:01 By Nasdaq GlobeNewswire
-
Ultragenyx to Host Conference Call for Third Quarter 2022 Financial Results and Corporate Update
27 Oct 2022 15:01:00 By Nasdaq GlobeNewswire
-
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04 Oct 2022 15:30:00 By Nasdaq GlobeNewswire
-
Ultragenyx and Mereo BioPharma to Present Setrusumab Data Update at ASBMR
09 Sep 2022 19:22:15 By Nasdaq GlobeNewswire
-
Ultragenyx to Participate at Citi BioPharma Conference
01 Sep 2022 15:01:00 By Nasdaq GlobeNewswire
-
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
17 Aug 2022 15:01:00 By Nasdaq GlobeNewswire
-
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
03 Aug 2022 15:05:02 By Nasdaq GlobeNewswire
-
Ultragenyx Reports Second Quarter 2022 Financial Results and Corporate Update
28 Jul 2022 15:01:00 By Nasdaq GlobeNewswire
-
Ultragenyx to Host Conference Call for Second Quarter 2022 Financial Results and Corporate Update
25 Jul 2022 15:01:00 By Nasdaq GlobeNewswire
-
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
20 Jul 2022 16:09:15 By Nasdaq GlobeNewswire